Alumis Inc. (ALMS) vs Jade Biosciences, Inc. (JBIO)
A side-by-side comparison of Alumis Inc. and Jade Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALMS
Alumis Inc.
$6.71HealthcareDelayed quote: Oct 6, 2026, 10:45 AM EDT
JBIO
Jade Biosciences, Inc.
$13.47HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
Total return — ALMS vs JBIO
growth of $100 · dividends reinvested · last 2yALMS -48.6% (-28.3%/yr)JBIO -70.2% (-45.4%/yr)ALMS compounded faster over this window
ALMS JBIO
ALMS vs JBIO: by the numbers
- •ALMS is the larger company ($828M vs $820M market cap).
- •Both run net losses; JBIO's is the smaller (0.00% vs -5933.45% net margin).
Metrics side by side
Valuation
| Metric | ALMS | JBIO |
|---|---|---|
| P/S ratio | 111.87 | N/A |
| P/B ratio | 1.83 | 1.86 |
Profitability
| Metric | ALMS | JBIO |
|---|---|---|
| Gross margin | 88.23% | 0.00% |
| Operating margin | -1776.32% | 0.00% |
| Net margin | -5933.45% | 0.00% |
| ROE | -97.08% | -34.83% |
| ROIC | -94.76% | -37.39% |
Growth (annualized)
| Metric | ALMS | JBIO |
|---|---|---|
| Total return CAGR (5Y) | N/A | -52.65% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.